Help shape USP’s approach to alternative technologies.

USP is seeking pharmacist feedback on a proposed risk-based framework for evaluating and validating alternative technologies under USP <797>. Read the article with a free USP–NF account and submit comments by November 30, 2026.

The Wall Street Journal reports that Americans are injecting unapproved peptides sold under that...

If you’re in APC’s District II (from DC up through New England), don’t miss your virtual town hall...

A new analysis by U.S. Pharmacopeia found mixed news about drug shortages: On the one hand, the...

Help shape USP’s approach to alternative technologies.

Related posts

“For research use only” is doing a lot of heavy lifting.

District II: Your town hall is coming up

Let’s talk today’s shortages